Cargando…
Circulating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancer
Although neoadjuvant chemoradiotherapy (CRT) is the standard treatment for advanced rectal cancer (RC), markers to predict the treatment response have not been fully established. In 73 patients with advanced RC who underwent CRT in a neoadjuvant setting, we retrospectively examined the associations...
Autores principales: | Kitayama, Joji, Yasuda, Koji, Kawai, Kazushige, Sunami, Eiji, Nagawa, Hirokazu |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2894847/ https://www.ncbi.nlm.nih.gov/pubmed/20525293 http://dx.doi.org/10.1186/1748-717X-5-47 |
Ejemplares similares
-
Circulating lymphocyte is an important determinant of the effectiveness of preoperative radiotherapy in advanced rectal cancer
por: Kitayama, Joji, et al.
Publicado: (2011) -
Density of CD4(+) and CD8(+) T lymphocytes in biopsy samples can be a predictor of pathological response to chemoradiotherapy (CRT) for rectal cancer
por: Yasuda, Koji, et al.
Publicado: (2011) -
Prediction of the preoperative chemoradiotherapy response for rectal cancer by peripheral blood lymphocyte subsets
por: Tada, Noriko, et al.
Publicado: (2015) -
Immunohistochemical detection of CD133 is associated with tumor regression grade after chemoradiotherapy in rectal cancer
por: Hongo, Kumiko, et al.
Publicado: (2012) -
Recent advances in neoadjuvant chemoradiotherapy in locally advanced rectal cancer
por: Kawai, Kazushige, et al.
Publicado: (2018)